TrialBreast cancer research and treatment2014

A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer.

Wolfgang Janni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.